Tag: atherosclerosis

1. FDC obicetrapib plus ezetimibe significantly decreased LDL cholesterol levels by 48.6% compared to placebo. 2. Serious adverse events were ...

1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...

1. In a retrospective cohort study, the distribution of low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) levels obtained ...

1. High-sensitivity C-reactive protein increased the risk of all-cause mortality by two- to three-fold among all three randomized trials. 2. ...

1. In this systematic review and network meta-analysis, resistance training, high-intensity interval training (HIIT), and aerobic exercise interventions were superior ...

Exercise improves arterial stiffness in children and adolescents 1. In this systematic review and network meta-analysis, resistance training, high-intensity interval ...

1. In this population-based cross-sectional study, among 10 528 Swedish women undergoing coronary computed tomography (CT) angiography, there was a ...

1. In patients with type 2 diabetes and hypertriglyceridemia, pemafibrate did not alter the incidence of cardiovascular events compared to placebo. ...

1. Olpasiran significantly and substantially reduced lipoprotein(a) concentration in patients with atherosclerotic cardiovascular disease compared to placebo. 2. Olpasiran reduced ...

1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups. ...